Corcept Therapeutics Incorporated Stock Price on May 5, 2022
| CORT Stock | USD 22.48 0.52 2.26% |
Below is the normalized historical share price chart for Corcept Therapeutics Incorporated extending back to April 14, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Corcept Therapeutics stands at 22.48, as last reported on the 24th of April, with the highest price reaching 23.29 and the lowest price hitting 22.05 during the day.
If you're considering investing in Corcept Stock, it is important to understand the factors that can impact its price. We consider Corcept Therapeutics very steady. Corcept Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0019, which signifies that the company had a 0.0019% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Corcept Therapeutics Incorporated, which you can use to evaluate the volatility of the firm. Please confirm Corcept Therapeutics' Mean Deviation of 2.18, risk adjusted performance of (0), and Standard Deviation of 2.78 to double-check if the risk estimate we provide is consistent with the expected return of 0.0054%.
At this time, Corcept Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 652.6 M in 2024, whereas Other Stockholder Equity is likely to drop slightly above 98.3 M in 2024. . At this time, Corcept Therapeutics' Price Earnings Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 6.97 in 2024, whereas Price To Sales Ratio is likely to drop 6.62 in 2024. Corcept Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of April 2004 | 200 Day MA 26.5714 | 50 Day MA 23.8738 | Beta 0.477 |
Corcept |
Sharpe Ratio = 0.0019
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CORT |
Estimated Market Risk
| 2.8 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Corcept Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Corcept Therapeutics by adding Corcept Therapeutics to a well-diversified portfolio.
Price Book 4.8158 | Enterprise Value Ebitda 18.8985 | Price Sales 5.0608 | Shares Float 84.8 M | Wall Street Target Price 42.8 |
Related Headline
Mineralys Therapeutics Headline on 9th of February 2023
Mineralys Therapeutics, exotic insider transaction detected by Akkaraju Srinivas
Filed transaction by Mineralys Therapeutics In director. Unconventional Insider trading
Corcept Therapeutics Valuation on May 5, 2022
It is possible to determine the worth of Corcept Therapeutics on a given historical date. On May 5, 2022 Corcept was worth 22.1 at the beginning of the trading date compared to the closed value of 21.32. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Corcept Therapeutics stock. Still, in general, we apply an absolute valuation method to find Corcept Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Corcept Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Corcept Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 21.95 | 22.29 | 21.02 | 22.22 | 958,100 | |
05/05/2022 | 22.10 | 22.10 | 21.03 | 21.32 | 1,128,700 |
| 20.68 | 20.93 | 18.90 | 19.20 | 2,232,000 |
| Backtest Corcept Therapeutics | | | Corcept Therapeutics History | | | Corcept Therapeutics Valuation | Previous | Next |
Corcept Therapeutics Trading Date Momentum on May 5, 2022
| On May 06 2022 Corcept Therapeutics Incorporated was traded for 19.20 at the closing time. The top price for the day was 20.93 and the lowest listed price was 18.90 . The trading volume for the day was 2.2 M. The trading history from May 6, 2022 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 9.94% . The overall trading delta against the current closing price is 11.16% . |
Corcept Therapeutics Fundamentals Correlations and Trends
By evaluating Corcept Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Corcept Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Corcept financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Corcept Therapeutics Stock history
Corcept Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Corcept is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Corcept Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Corcept Therapeutics stock prices may prove useful in developing a viable investing in Corcept Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 111.7 M | 83.1 M | |
| Net Income Applicable To Common Shares | 116.5 M | 122.3 M |
Corcept Therapeutics Quarterly Net Working Capital |
|
Corcept Therapeutics Stock Technical Analysis
Corcept Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Corcept Therapeutics Period Price Range
Low | May 5, 2022
| High |
22.10 | 21.32 |
Corcept Therapeutics April 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Corcept Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Corcept Therapeutics shares will generate the highest return on investment. By undertsting and applying Corcept Therapeutics stock market strength indicators, traders can identify Corcept Therapeutics Incorporated entry and exit signals to maximize returns
| Accumulation Distribution | 54647.47 | |||
| Daily Balance Of Power | (0.73) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 21.57 | |||
| Day Typical Price | 21.48 | |||
| Price Action Indicator | (0.64) | |||
| Period Momentum Indicator | 1.16 | |||
| Relative Strength Index | 66.77 |
Corcept Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Corcept Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Corcept Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Corcept to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (0.03) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Corcept Therapeutics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Corcept Stock analysis
When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Corcept Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Corcept Therapeutics. If investors know Corcept will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Corcept Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.995 | Earnings Share 0.94 | Revenue Per Share 4.658 | Quarterly Revenue Growth 0.314 | Return On Assets 0.1113 |
The market value of Corcept Therapeutics is measured differently than its book value, which is the value of Corcept that is recorded on the company's balance sheet. Investors also form their own opinion of Corcept Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Corcept Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Corcept Therapeutics' market value can be influenced by many factors that don't directly affect Corcept Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Corcept Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Corcept Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Corcept Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.